Article No
AG-MR-C0002-M025
CAS No | 186692-45-5 |
MW | 354.5 |
Article No | AG-MR-C0002-M025 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
Description | (S)-Roscovitine |
Supplier | Adipogen Life Sciences |
Format | Powder |
Notes | (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound.|Chemical. CAS: 186692-45-5. Formula: C19H26N6O. MW: 354.5. (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound. |
Molecular Formula | C19H26N6O |
Alias Names | 6-Benzylamino-2-(S)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine |
Product Type | Chemicals & Biochemicals |
Purity | >99% |
Research area | Cell Death |
Shipping Information | RT |
Size | 25 mg |
Solubility | Soluble in DMSO, ethanol or methanol. |
Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Storage | -20°C, 4°C |
Technical Specifications | Chemical. CAS: 186692-45-5. Formula: C19H26N6O. MW: 354.5. (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound. |
Product Page Updated | 2024-02-01T08:25:01.492Z |